Spectral AI Inc (NASDAQ:MDAI) announced that it has been awarded more than $850,000 from the Medical Technology Enterprise Consortium (MTEC), a biomedical group collaborating with the US Army Medical Material Development Activity, to support the ongoing development of its DeepView SnapShot M.
Spectral AI’s DeepView SnapShot M is a handheld predictive wound healing device targeting battlefield applications based on its AI-driven DeepView System Platform, which uses multispectral imaging trained against a database of more than 340 billion clinically validated data points to assess a burn wound’s healing potential before other medical intervention.
The DeepView SnapShot M is designed to be a key part of the triage process by providing a fast and accurate wound assessment so those with more severe injuries can be prioritized for evacuation.
Spectral AI said the development of its device aligns with MTEC’s goal of facilitating the advancement of technologies that optimize the health and performance of US military service personnel.
“We are developing DeepView SnapShot M to address the critical need to deliver portable, rapid, informed, and potentially lifesaving diagnoses in combat zones and military hospitals,” Spectral AI CEO Peter Carlson commented.
“The development of this device reflects the platform nature of our DeepView System, its robust architecture, and a broad range of potential applications across diverse environments.”
The company highlighted that including this award funding, total non-dilutive government funding for the DeepView SnapShot M has topped $7 million.
“We are grateful for the continuing support of our government partners and for the collaborative nature of our relationships with clinicians who are evaluating the device,” Carlson added.
“By gathering and applying their real-world usage feedback, we can make iterative improvements that support the pathway from product development to commercialization.”